ArticleScientific reports2025
Single-cell and bulk transcriptomics reveal Fusobacterium nucleatum promotes colorectal cancer metastasis by upregulating LAMC2 in in vitro and in vivo models.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Colorectal cancer (CRC) is one of the most prevalent malignancies worldwide. Fusobacterium nucleatum (F. nucleatum) has been strongly implicated in CRC metastasis. However, the contribution of laminin γ2 chain (LAMC2) to F. nucleatum-induced CRC metastasis remains elusive. We investigated the role of LAMC2 in F. nucleatum-induced CRC cell migration through a series of in vitro assays, including transmission electron microscopy, wound-healing, and transwell migration experiments, as well as in vivo animal models. Additionally, we explored the expression profile of LAMC2 in CRC tissues and assessed its prognostic relevance using immunohistochemistry, bulk transcriptome, and single-cell transcriptomics analyses. We found that F. nucleatum upregulates LAMC2 expression, thereby promoting CRC cell migration. Mechanistic analyses revealed that F. nucleatum downregulates hsa-miRNA-7977, releasing its transcriptional repression of LAMC2. Additionally, LAMC2 activates the FAK-PI3K-AKT signaling pathway and modulates H3K27 histone acetylation. Immunohistochemistry, together with single-cell and bulk transcriptome analyses, demonstrated that LAMC2 is highly expressed in metastatic CRC tissues, and is significantly associated with poor prognosis. Moreover, a Cox regression-based prognostic model constructed using LAMC2-associated genes exhibited robust predictive performance across multiple independent cohorts. Our findings identify LAMC2 as a key mediator of F. nucleatum-induced CRC metastasis and highlight it as both a prognostic biomarker and a potential therapeutic target.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.